Related Experiment Video
Updated: May 26, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Age-related differences in the clinical characteristics of systemic lupus erythematosus in children
Jia Zhu1, Fengqi Wu, Xiaolan Huang
1Division of Pediatric Rheumatology, Children's Hospital Affiliated Capital Institute of Pediatrics, No.2 Yabao Road, Chaoyang District, Beijing 100020, China.
Insights
Pediatric systemic lupus erythematosus (pSLE) presentation varies by age. Preschoolers show shorter disease duration, more neuropsychiatric issues, and poorer outcomes, while adolescents have peak incidence and adult-like characteristics.
Area of Science:
- Rheumatology
- Pediatrics
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- Pediatric SLE (pSLE) presents unique challenges in diagnosis and management.
- Understanding age-specific clinical variability is crucial for effective treatment.
Purpose of the Study:
- To investigate how the clinical presentation of pediatric SLE differs based on age of onset.
- To compare clinical manifestations, disease activity, and prognosis across different pediatric age groups.
Main Methods:
- Retrospective chart review of 88 Chinese pediatric SLE patients diagnosed between 2005-2008.
- Patients categorized into preschool (1-6 yrs), school-age (7-11 yrs), and adolescent (12-18 yrs) groups.
- Comparison of demographic data, onset symptoms, clinical features, laboratory findings, SLEDAI, and SLICC/ACR SDI.
Main Results:
- Adolescents comprised the largest group (47.7%).
- Preschoolers had the shortest disease duration (0.65 ± 0.5 months), highest neuropsychiatric involvement, and poorest prognosis, particularly boys.
- Common onset symptoms included fever, rash, arthritis, and seizures, with frequent hematologic and neuropsychiatric damage.
Conclusions:
- Age at onset significantly influences pSLE clinical presentation, disease activity, and prognosis.
- Preschool-onset pSLE is associated with aggressive disease and poorer outcomes.
- Adolescent-onset pSLE shows peak incidence and begins to exhibit adult-like characteristics, highlighting the need for age-tailored management strategies.
Abstract:
The objective of this study was to determine how the clinical presentation of systemic lupus erythematosus in pediatric varied with the age of onset of the disease. We reviewed the charts of a total of 88 Chinese pediatric patients (pSLE) diagnosed and admitted first time to our hospitals between 2005 and 2008. Patients were divided into 3 groups, depending on the age at diagnosis: preschool (1-6 years), school age (7-11 years), and adolescent groups (12-18 years). Among the three groups, we compared the sex ratio, disease duration at diagnosis, symptoms at the onset of the disease, clinical manifestations, laboratory examinations, SLEDAI (Systemic Lupus Erythematosus Disease Activity Index) 2000, and SLICC/ACR SDI (Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for Systemic Lupus Erythematosus). Most pediatric patients were in the adolescent group (47.7%), while the disease duration at diagnosis was shortest in preschool-age patients (0.65 ± 0.5 months). The most common symptoms at the onset of pSLE were fever, rash, arthritis, and seizures. Hematologic system and neuropsychiatric system were damaged commonly. The preschool-age patients had the shortest disease duration at diagnosis, the highest incidence of neuropsychiatric system involvement, and the poorest prognosis of all the age groups, especially the boys. Patients in adolescence had the peak incidence of pediatric SLE and high disease activity, begins to acquire some of the adult characteristics. School-age is a transition stage between other stages.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Multiple Sclerosis l: Introduction
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
